TLDR Women with PCOS had higher SRAGE levels, possibly linked to BMI, not PCOS.
The study investigated serum levels of soluble receptors for advanced glycosylated end-products (SRAGE) in 30 women with polycystic ovarian syndrome (PCOS) and compared them to 30 women without PCOS, all aged 18-35 years. The results indicated an increase in serum SRAGE levels in the PCOS group compared to the control group; however, this increase was not statistically significant. Furthermore, there was a negative correlation between serum SRAGE levels and BMI and waist circumference in the PCOS group, but no correlation with hormonal parameters such as FSH, LH, and testosterone. The study suggested that while SRAGE levels were elevated in women with PCOS, this might be related to BMI rather than PCOS itself.
1744 citations,
August 2006 in “The Journal of Clinical Endocrinology and Metabolism” Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.
[object Object]
25 citations,
June 2012 in “Endocrine” PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.
37 citations,
October 2021 in “Nutrients” Vitamin D might help regulate insulin in the body, but taking Vitamin D supplements doesn't clearly prevent or improve type 2 diabetes. More research is needed.
[object Object] 251 citations,
October 2014 in “The Journal of Clinical Endocrinology & Metabolism” The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.
10 citations,
November 2018 in “Physiological Research” The conclusion is that standardizing testosterone measurement methods is essential for better diagnosis accuracy in women.
1341 citations,
January 2014 in “Cardiology Research and Practice” Managing metabolic syndrome needs both lifestyle changes and medical treatments.